Placental malaria increases mother-to-child HIV transmission

November 05, 2003

Placental malaria infection during pregnancy significantly increases the risk of mother-to-child transmission of HIV, according to researchers at the Johns Hopkins Bloomberg School of Public Health.

Their study of HIV-positive women living in Rakia, Uganda found that the mother-to-child HIV transmission rates were 40 percent among women with placental malaria compared to 15.4 percent for women without malaria. The researchers believe that interventions to prevent malaria during pregnancy could potentially reduce mother-to-child transmission of HIV. The study, which is the first to look at the effects of placental malaria in mother-to-child HIV transmission, is published in the November 2003, issue of the scientific journal AIDS.

"Our findings show that co-infection with placental malaria and HIV during pregnancy significantly increases the risk of HIV transmission from mother to newborn. Preventing and treating malaria during pregnancy could be a beneficial and cost effective means of reducing the transmission of HIV from mother to newborn," said Heena Brahmbhatt, PhD, MPH, lead author of the study and an assistant scientist with the Department of Population and Family Health Sciences at the School of Public Health. Dr. Brahmbhatt added that HIV and malaria are among the most prevalent infectious diseases in sub-Saharan Africa.

For the study, Dr. Brahmbhatt and her colleagues followed 746 HIV-positive mothers and their infants living in Rakai, Uganda between 1994 and 1999. The participants were enrolled from a larger study of maternal and infant health and the treatment of sexually transmitted diseases during pregnancy. Malaria parasite infection was measured in the mother's placenta and was found to be more common in HIV-positive women than in those who were HIV-negative. HIV transmission from mother to child occurred 20 percent of the time among all of the participants, but was substantially higher if the mother had placental malaria.

"These findings could have potential public health relevance because interventions to prevent placental malaria during pregnancy might reduce the risk of HIV transmission from mother to child and this could augment current approaches using antiretroviral drugs. Randomized trails of intensive malaria control in HIV-positive women are urgently needed," said Dr. Brahmbhatt.
-end-
"The effects of placental malaria on mother-to-child HIV transmission in Rakai, Uganda" was written by Heena Brahmbhatt, Godfrey Kigozi, Fred Wabwire-Mangen, David Serwadda, Nelson Sewakambo, Tom Lutalo, Maria Wawer, Carlos Abramowsky, David Sullivan and Ronald Gray.

The study was funded by the Johns Hopkins Malaria Research Institute.

News releases from the Johns Hopkins Bloomberg School of Public Health are available at http://www.jhsph.edu/Press_Room.

Johns Hopkins University Bloomberg School of Public Health

Related Malaria Articles from Brightsurf:

Clocking in with malaria parasites
Discovery of a malaria parasite's internal clock could lead to new treatment strategies.

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the UmeƄ University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.

Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.

New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.

Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.

Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.

Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.

Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.

Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.

The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.

Read More: Malaria News and Malaria Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.